R
Ravi Bhatia
Researcher at University of California, Los Angeles
Publications - 17
Citations - 329
Ravi Bhatia is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Percutaneous coronary intervention & Conventional PCI. The author has an hindex of 5, co-authored 15 publications receiving 320 citations. Previous affiliations of Ravi Bhatia include City of Hope National Medical Center.
Papers
More filters
Journal ArticleDOI
Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment
Su Chu,Helen Xu,Helen Xu,Neil P. Shah,Neil P. Shah,David S. Snyder,David S. Snyder,Stephen J. Forman,Stephen J. Forman,Charles L. Sawyers,Charles L. Sawyers,Ravi Bhatia,Ravi Bhatia +12 more
TL;DR: It is concluded that BCR-ABL kinase mutations can be detected in CD34+ cells from CML patients in CCR on imatinib, may contribute to persistence of small populations of malignant progenitors, and could be a potential source of relapse.
Journal ArticleDOI
Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug‐eluting stents in patients with myocardial infarction
Michael S. Lee,Dario Sillano,Azeem Latib,Alaide Chieffo,Giuseppe Biondi Zoccai,Ravi Bhatia,Imad Sheiban,Antonio Colombo,Jonathan M. Tobis +8 more
TL;DR: PCI with DES appears to be technically feasible, associated with acceptable long‐term outcomes, and a reasonable alternative to surgical revascularization for MI patients with ULMCA disease.
Journal Article
Causes of Death in Patients undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents in a Real-World Setting
TL;DR: Cardiac and non-cardiac causes of death contributed similarly to mortality in patients who underwent PCI with DES at a large tertiary care center that manages high-risk patients.
Journal ArticleDOI
Impact of diabetes and acute coronary syndrome on survival in patients treated with drug-eluting stents.
Michael S. Lee,Michael S. Lee,Daniel Jurewitz,Raymond Zimmer,Antonio M Pessegueiro,Ravi Bhatia,Jesse Currier,Larry Yeatman,Jonathan M. Tobis +8 more
TL;DR: Diabetics who undergo percutaneous coronary intervention (PCI) are at increased risk for death, myocardial infarction, repeat revascularization, and stent thrombosis.
Journal ArticleDOI
Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: A multicenter Southern Californian Registry†
Michael S. Lee,Patrick Hu,Joseph Aragon,Atman P. Shah,Ravi Bhatia,Nathaniel Jones,William F. Penny,William J. French,Jonathan M. Tobis,Ehtisham Mahmud +9 more
TL;DR: Patients with CRI who underwent SVG intervention with DES had higher risks of MACE and death compared with patients with preserved renal function, and CRI was the only significant predictor of 1‐year MACE.